FY21 Results Presentation
Filed with ASX · · 21 pages · English
This presentation has been prepared by Atomo Diagnostics Limited (“Atomo”) based on information available as at the date of this presentation. The information in this presentation is provided in summary form and does not contain all information necessary to make an investment decision. Reliance should not be placed on the information or opinions contained in this presentation. An investor must not
In the deck
Story so far
Earlier from Atomo Diagnostics
- Appendix 4E & Annual Financial Report
- Quarterly Activity Report - 30 June 2021
- Appendix 4C - 30 June 2021
- Access Bio receives FDA clearance for COVID-19 antibody test
- Update to Atomos US market strategy
Later from Atomo Diagnostics
- Atomo and Access Bio renegotiate supply agreements
- Appendix 4C - 30 September 2021
- Quarterly Activity Report - 30 September 2021
- HIV Self-Test - improved supply & advertising conditions
- Appendix 4C - 31 December 2021
Follow Atomo Diagnostics into a list and get an email when it puts out news.
Follow Atomo Diagnostics